Merck to present new data for 4 approved oncology medicines and 4 pipeline candidates in more than 25 types of cancer at ...
Merck, known as MSD outside of the United States and Canada, announced that new data for four approved oncology medicines and four pipeline candidates in more than 25 types of cancer will be presented at the 2024 American Society of Clinical Oncology (ASCO …